These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26461413)

  • 1. NASH (Nonalcoholic steatohepatitis): A case of multiorganelle failure.
    Caldwell S
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S6. PubMed ID: 26461413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):213-22. PubMed ID: 21476916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular ballooning in NASH.
    Caldwell S; Ikura Y; Dias D; Isomoto K; Yabu A; Moskaluk C; Pramoonjago P; Simmons W; Scruggs H; Rosenbaum N; Wilkinson T; Toms P; Argo CK; Al-Osaimi AM; Redick JA
    J Hepatol; 2010 Oct; 53(4):719-23. PubMed ID: 20624660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma.
    de Lima VM; Oliveira CP; Alves VA; Chammas MC; Oliveira EP; Stefano JT; de Mello ES; Cerri GG; Carrilho FJ; Caldwell SH
    J Hepatol; 2008 Dec; 49(6):1055-61. PubMed ID: 18929425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and cytokines in non-alcoholic steatohepatitis.
    Syn WK; Choi SS; Diehl AM
    Clin Liver Dis; 2009 Nov; 13(4):565-80. PubMed ID: 19818305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
    Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
    Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.
    Fujii H; Ikura Y; Arimoto J; Sugioka K; Iezzoni JC; Park SH; Naruko T; Itabe H; Kawada N; Caldwell SH; Ueda M
    J Atheroscler Thromb; 2009; 16(6):893-901. PubMed ID: 20032580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
    Straub BK; Schirmacher P
    Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise.
    Passos E; Ascensão A; Martins MJ; Magalhães J
    Metabolism; 2015 Jul; 64(7):780-92. PubMed ID: 25838034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological Findings of NASH and NAFLD: for Guidebook of NASH and NAFLD, 2015: The Japan Society of Hepatology.
    ;
    Hepatol Res; 2017 Jan; 47(1):3-10. PubMed ID: 27889947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
    Tiniakos DG
    Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.